| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Lushang Freda Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.72 |
| 52 Week High | CN¥11.38 |
| 52 Week Low | CN¥6.38 |
| Beta | 1.92 |
| 1 Month Change | -8.53% |
| 3 Month Change | -18.05% |
| 1 Year Change | -31.44% |
| 3 Year Change | -49.54% |
| 5 Year Change | 94.95% |
| Change since IPO | -13.33% |
Recent News & Updates
Is Now An Opportune Moment To Examine Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)?
Apr 16
Lushang Freda PharmaceuticalLtd's (SHSE:600223) Solid Earnings May Rest On Weak Foundations
Mar 28Recent updates
Is Now An Opportune Moment To Examine Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)?
Apr 16Lushang Freda PharmaceuticalLtd's (SHSE:600223) Solid Earnings May Rest On Weak Foundations
Mar 28Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Mar 04A Look At The Fair Value Of Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)
Feb 27Shareholder Returns
| 600223 | CN Real Estate | CN Market | |
|---|---|---|---|
| 7D | 0.9% | -1.4% | 0.06% |
| 1Y | -31.4% | -24.4% | -16.1% |
Return vs Industry: 600223 underperformed the CN Real Estate industry which returned -24.4% over the past year.
Return vs Market: 600223 underperformed the CN Market which returned -16.1% over the past year.
Price Volatility
| 600223 volatility | |
|---|---|
| 600223 Average Weekly Movement | 5.8% |
| Real Estate Industry Average Movement | 6.9% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.2% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 600223's share price has been volatile over the past 3 months.
Volatility Over Time: 600223's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 3,651 | n/a | www.lshzy.com.cn |
Lushang Freda Pharmaceutical Co.,Ltd. develops and operates real estate properties in China. The company offers property management services, such as non-owner value-added and community value-added services.
Lushang Freda Pharmaceutical Co.,Ltd. Fundamentals Summary
| 600223 fundamental statistics | |
|---|---|
| Market cap | CN¥7.85b |
| Earnings (TTM) | CN¥233.09m |
| Revenue (TTM) | CN¥4.20b |
33.7x
P/E Ratio1.9x
P/S RatioIs 600223 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600223 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.20b |
| Cost of Revenue | CN¥2.12b |
| Gross Profit | CN¥2.07b |
| Other Expenses | CN¥1.84b |
| Earnings | CN¥233.09m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 49.39% |
| Net Profit Margin | 5.55% |
| Debt/Equity Ratio | 13.7% |
How did 600223 perform over the long term?
See historical performance and comparison